Dr. Segundo Mesa Castillo is an experienced Neurology Specialist with a decade of dedicated service at the Institute of Neurology in Havana, Cuba. His career spans over 32 years of research focused on Electron Microscopy in Schizophrenia. He has been honored with the prestigious International Prize from the Stanley Foundation Award Program. Additionally, he was selected by the Professional Committee for a fellowship at the Laboratory of Central Nervous System Studies, National Institute of Neurological Diseases and Stroke, under the mentorship of Dr. Joseph Gibbs. This six-month fellowship took place at the National Institutes of Health in Bethesda, Washington, D.C., USA.

Dr. Ian James Martins is an Editor/Reviewer for Open Acess Pub/MDPI journals, Frontiers, Scientific Reports (Nature), PLOS ONE and various other international journals. Advisory Board Member for Photon Journal. His expertise has earned him a position on the Advisory Board for Photon Journal and the honor of being a Top Peer Reviewer, ranking in the top 1% in 22 Essential Science Indicators fields. Dr. Martins has served as Chief Editor for several prestigious journals in the realms of diabetes, neuroscience, nutrition, endocrinology, and metabolism. With an impressive h-index of 132 and over 15,474 citations in the past 27 years, he has been awarded 182 international certificates and boasts a Research Gate score higher than 97.5% of global scientists.

Prof. Rouse is a native of England where he completed his education through a BVSc honors degree. Graduate education in Canada with MSc in Virology and PhD in immunology Postdoctoral fellowship at Walter and Eliza Hall of Medical Research in Melbourne Australia in Cellular Immunology 1970-72.Established research Program at University of Saskatchewan on Viral immunology supported by Medical Research Council of Canada. Moved to College of Veterinary Medicine University of Tennessee in 1977 where he remains as the Lindsay Young Distinguished Professor. Took several mainly sabbaticals, including one with Peter Doherty (another veterinarian) in Canberra and Hermann Wagner for one year in Mainz, Germany Worked on the immunology of herpes virus infections supported continuously by multiple NIH grants until the lad was closed in Dec 2022.Published >470 research articles and reviews with and h index 91 and won several Research Achievement awards. Trained 80 PhD and postdoctoral fellows most of whom he stays in contact and occasionally writes reviews on topics in Viral Immunology.

Dr. De-chu Chris Tang is the Founder CEO of VaxDome Inc. He and his associates were the first to have developed DNA vaccines, skin-patch vaccines, antiviral/vaccine hybrids and in vivo cytotoxicity assay, etc. Dr. Tang obtained his PhD degree from Indiana University. He founded Vaxin Inc. when he was an assistant professor at University of Alabama at Birmingham. VaxDome Inc. is located on University of North Texas Health Science Center campus, with a focus on the development of an antiviral vaccine/vaccine potentiator package without constraints imposed by viral mutations; as well as a tissue resident cellular immunity assay with missing-in-action T cells excluded.

Naoki Ikegami is Professor Emeritus at Keio University, Tokyo. He was Chair of the Department of Health Policy and Management at the Keio School of Medicine, from which he received his MD and PhD. He also received a Master of Arts with Distinction in health services studies from Leeds University (United Kingdom). He has been a visiting professor at the University of Pennsylvania’s Wharton School and Medical School, and President of the Japan Society of Healthcare Administration and the Japan Health Economics Association.

Prof. Dr. Ljudmila Stojanovich, MD, PhD, FRCP, is a prominent specialist in autoimmune rheumatic diseases, focusing on Systemic Lupus Erythematosus (SLE), Antiphospholipid Syndrome (APS), and vaccination in autoimmune patients. She earned her Ph.D. in 1999 with a thesis on neuropsychiatric manifestations in SLE. Prof. Stojanovich has published over 250 scientific papers and three monographs, contributing extensively to autoimmune disease research. She serves on the editorial boards of leading journals, including Lupus (London) and The Journal of Rheumatology, and is Associate Editor for Frontiers in Medicine and Frontiers in Immunology. She is involved in international research collaborations, such as EULAR initiatives on vaccination and APS management. Prof. Stojanovich has been a speaker, chair, and organizer at numerous international conferences, including the 12th European Forum on Antiphospholipid Antibodies. Her work has earned her an h-index of 36 and over 5,000 citations, reflecting her global impact in rheumatology.

Dr. Pongsak Rattanachaikunsopon is a Professor in the Department of Biological Science at Ubon Ratchathani University, Thailand. He obtained Bachelor of Science in Radiological Technology at Mahidol University, Thailand and a Master of Science in Anatomy at Mahidol University, Thailand. He earned Ph.D. in Molecular Biology at Lehigh University, Pennsylvania USA. He has been awarded with Professor Sood Saengvichain Award for Best Research and Presentation in 13th Annual Meeting of the Society of Anatomy of Thailand in 1990, Professor Dr. Tab Nilanidhi Foundation Award for the outstanding graduate student in Anatomy in 1991 and Best Government Officer, The Ministry of Education in 2014. He serves as an Editorial board member of more than 10 international Journals.

Dr. Weronika Dardzińska, PhD, DVM is a pharmacovigilance and clinical-development leader with 15 years of global experience in drug safety science, AI driven data review and front line patientcare. She has deep therapeutic expertise in oncology (NSCLC, multiplemyeloma) and respiratory disease (COPD, asthma), gained through safety roles at GSK, MSD and TFS. Weronika pairs her doctorate with postgraduate training in epidemiology, biostatistics, computational biopharmacy and pharmacoeconomics/HTA, weaving real world evidence and population models into drug-safety decision making. Her current research interest lies in translating advanced analytics into measurable improvements in patient quality of life and outcomes.